Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial. (Q51355147)
Jump to navigation
Jump to search
scientific article published on 19 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial. |
scientific article published on 19 July 2012 |
Statements
1 reference
Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial. (English)
1 reference
A Rissanen
1 reference
C P Howard
1 reference
J Botha
1 reference
T Thuren
1 reference
Global Investigators
1 reference
19 July 2012
1 reference
14
1 reference
12
1 reference
1088-1096
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference